Track Medline Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Medline Inc. MDLN · Stock Open Medline Inc. in new tab

40.47 USD
P/E
35.51
EPS
1.14
P/B
3.04
ROE
6.05
Target Price
50.92 USD
Loading chart...
Key Metrics
Earnings dateAug. 5, 2026
P/E35.51
EPS1.14
Book Value13.32
Price to Book3.04
Debt/Equity65.31
% Insiders0.208%
Growth
Revenue Growth0.11%
Earnings Growth-0.60%
Estimates
Forward P/E24.31
Forward EPS1.67
Target Mean Price50.92

DCF Valuation

Tweak assumptions to recompute fair value for Medline Inc. (MDLN)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Medline Inc. Logo Medline Inc. Analysis (MDLN)

Is Medline Inc. a good investment? Medline Inc. (MDLN) is currently trading at 40.47 USD. Market analysts have a consensus price target of 50.92 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 35.51. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Medline Inc. is expected to release its next earnings report on Aug. 5, 2026. The market consensus estimate for Forward EPS is 1.67.

Investor FAQ

Does Medline Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Medline Inc.?

Medline Inc. is classified as a Stock.

When is the next earnings date?

The next earnings date is projected to be Aug. 5, 2026. The company currently has a trailing EPS of 1.14.

Company Profile

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services, such as consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. The company was founded in 1966 and is based in Northfield, Illinois.

Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion